US Patent 11786603 Optimized transglutaminase site-specific antibody conjugation
Patent 11786603 was granted and assigned to Regeneron Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+21 properties)
Article (+142 characters)
US Patent 11786603 Optimized transglutaminase site-specific antibody conjugation
Article
Patent abstract
Provided herein are methods and compositions for site-specific conjugation of antibodies in the presence of a transglutaminase.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Amy Han
Christopher D'Souza
William Olson
Date of Patent
October 17, 2023
Patent Application Number
16079851
Date Filed
February 24, 2017
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11786603 Optimized transglutaminase site-specific antibody conjugation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
